Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 4.03% | 69.70 | 1.0% | $1071.78m | |
| BIIB | Biogen, Inc. | 0.02% | 336.71 | 1.5% | $665.47m | |
| AMGN | Amgen, Inc. | 0.29% | 222.79 | 1.3% | $550.81m | |
| ILMN | Illumina, Inc. | -1.50% | 295.94 | 3.5% | $414.21m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.49% | 246.29 | 1.9% | $346.37m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.01% | 403.15 | 2.6% | $345.56m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.59% | 103.14 | 2.0% | $220.13m | |
| A | Agilent Technologies, Inc. | 0.85% | 85.06 | 1.6% | $165.05m | |
| EXAS | EXACT Sciences Corp. | -2.59% | 99.98 | 24.0% | $144.57m | |
| INCY | Incyte Corp. | -2.27% | 80.89 | 2.5% | $113.92m | |
| SGEN | Seattle Genetics, Inc. | -1.12% | 117.00 | 6.1% | $113.16m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 6.13% | 95.16 | 4.3% | $102.95m | |
| MRNA | Moderna, Inc. | -1.67% | 18.23 | 0.0% | $98.70m | |
| XLRN | Acceleron Pharma, Inc. | -0.36% | 94.51 | 6.1% | $91.83m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -1.57% | 131.03 | 8.7% | $91.49m |
Company Profile
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.